How to empower and kickstart your H5N1 R&D projects? Take your vaccine and therapeutic development projects to the next level with our safe and functional H5N1 pseudoviruses. Designed to accurately replicate biological interactions, our pseudoviruses offer: ✅ Maximum Safety: Completely non-replicative. ✅ High Quality: Functionally validated batches for reliable results. ✅ Large-Scale Availability: Optimized production for your research needs. ✅ Customization: Tailored solutions to meet your specific requirements. 📩 Contact us today to move science forward faster with us. #H5N1 #influenza #VaccineResearch #Pseudovirus
IVANO Bioscience
Biotechnology Research
Quebec, quebec 1,374 followers
Neutralizing antibody detection tools driving vaccine and AAV gene therapy development, faster and easier.
About us
IVANO Bioscience's mission is to unleash the laboratory's ability to innovate. We design well-thought-out kits and reagents that remove the bottlenecks of the bio-industry and accelerate vaccine and drug discoveries. The company is developing the first neutralizing antibody detection technology based on artificial cells and artificial viruses that provides high-throughput and biologically relevant data within a day, while being BSL-1 convenient. As a complementary offer, IVANO Bioscience provides optimized and validated pseudoviruses in a large range of volumes. Our vision is to become an essential partner of the most promising vaccines and antiviral drugs discoveries.
- Website
-
https://www.ivanobioscience.com/
External link for IVANO Bioscience
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Quebec, quebec
- Type
- Privately Held
- Founded
- 2018
- Specialties
- biotechnology, bioprocess, pseudovirus, bioassay, biomanufacturing, viral vector, neutralization assay, vaccine screening, Hight-throughtput screening assay, infectious disease, and GPCR screening assay
Locations
-
Primary
Quebec, quebec G1V 0A6, CA
Employees at IVANO Bioscience
Updates
-
(English follows) IVANO Bioscience, en partenariat avec le professeur Bruno Gaillet du département de génie chimique de l’Université Laval recherche un candidat au doctorat motivé et passionné par la biotechnologie pour rejoindre son équipe. Le projet de recherche portera sur l’étude et l’optimisation de notre plateforme de fabrication de virus et de cellules artificiels. Ces bioparticules innovantes seront utilisées dans le développement de kits de détection pour diverses applications, notamment la conception de vaccins. Profil recherché : 📅 Disponibilité à partir de l’hiver 2025. 👩🔬 Expérience souhaitée dans les domaines suivants : génie cellulaire et des protéines, biologie moléculaire, et bioprocédés. 🎯 Sens de l’organisation, éthique de travail rigoureuse, et aisance à communiquer en français ou en anglais. 🎓 Diplôme de maîtrise en sciences ou en génie dans le domaine des sciences de la vie, ou toute autre expérience/formation pertinente. Candidature : Les personnes intéressées sont invitées à soumettre une lettre de motivation et un CV à [email protected]. Pour plus d'information : https://lnkd.in/eAWdHEs3 - IVANO Bioscience, in partnership with Professor Bruno Gaillet from the Department of Chemical Engineering at Université Laval, is seeking a motivated PhD candidate with a passion for biotechnology to join its team. The research project will focus on studying and optimizing our platform for producing artificial viruses and cells. These innovative bioparticles will be used to develop detection kits for various applications, including vaccine design. Candidate Profile: 📅 Available to start in Winter 2025. 👨🔬 Experience in the following areas: cell and protein engineering, molecular biology and bioprocessing. 🎯 Strong organizational skills, a solid work ethic, and proficiency in communicating in French or English. 🎓 A master’s degree in science or engineering in life science or any other relevant experience/education. Application: Interested candidates are invited to submit a cover letter and CV to [email protected] For more information: https://lnkd.in/eAWdHEs3
-
We are delighted to announce that the IVANO Bioscience team will be in Houston, Texas, from October 2 to 5! 🎉 We will be showcasing our neutralizing antibody detection tools, which accelerate result acquisition by 8 times—crucial for research on infectious diseases and AAV-based gene therapy. 🔗 Join us to see how we can transform your research! 📅 Date: October 2-5 📍 Location: Houston, Texas Special thanks to LE CAMP and Quebec International for the financial support. #InfectiousDisease #GeneTherapy #neutralizingTest #AAV
-
📣 We’re excited to announce the expansion of our team at IVANO Bioscience! Please join us in welcoming Elliot Grégoire, who is joining us as a Research Assistant. Elliot will support our research and logistical activities as we continue to drive innovation in health science. Elliot holds a Bachelor's degree in Biochemistry and is currently pursuing both a Bachelor's in Chemical Engineering and a Master’s in Business Administration at Université Laval. With a solid professional background and a wide range of skills, Elliot brings both versatility and experience to our team. Welcome aboard, Elliot! We’re looking forward to all the great things we will achieve together. 💪 #WelcomeToTheTeam #BiotechInnovation #ResearchAssistant #IVANOBioscience #NewHire
-
🎯 Do More with Less – Thanks to Our Pseudoviruses Why choose pseudoviruses? Because they can help you cut up to 70% of the costs associated with testing original viruses! At IVANO Bioscience, we offer a range of safe, reliable, and readily available pseudoviruses. Simplify your neutralization studies while enhancing the safety of your research team. Explore our catalog today and unlock more efficient solutions for your research! #Pseudovirus #VaccineDevelopment #NeutralizationAssays #easyresearch
-
🚀 We are excited to announce that IVANO Bioscience is now a proud member of the RRPV | Rapid Response Partnership Vehicle network! 🎉 As part of this dynamic consortium, we will collaborate with a vast network of innovators, technologists, and research institutions to support the development of solutions against infectious diseases. With our cutting-edge pseudovirus technology and advanced detection kits, we are well-positioned to contribute to the fight against pandemic influenza, emerging infectious diseases, and other biological threats. Together with RRPV and Biomedical Advanced Research and Development Authority (BARDA), we are dedicated to advancing Medical Countermeasures, strengthening global health security, and ensuring rapid responses to future public health emergencies. Stay tuned for more updates as we work to make a difference! 💡🔬 #Innovation #Biotech #InfectiousDiseases #HealthSecurity #Pseudovirus #DetectionKits #PandemicPreparedness #IVANOBioscience
-
📣 Partnering Announcement!!! We’re thrilled to announce that we have entered into a distribution agreement with IBT Bioservices! 🎉 After meeting with Shweta Kailasan, Ph.D. and Siddharth Rohankhedkar at The World Vaccine Congress – Washington 2024, our discussions led to this exciting collaboration! Through IBT Bioservices, a leading CRO that provides preclinical research services such as animal models, in vitro assays, and vaccine development for infectious diseases like influenza, our LV-based pseudoviruses for select pathogens will be even more readily available to researchers across the U.S. This partnership will enable us to better support companies in their drug discovery and vaccine development efforts, ultimately helping to improve human health. #collaboration #drugdiscovery #biotech #research #vaccinedevelopment #pseudovirus #influenzaresearch
-
🎉 Exciting News at IVANO Bioscience! 🎉 We are thrilled and grateful to announce that IVANO has been awarded a significant grant from the Mouvement des accélérateurs d'innovation du Québec, Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada. This incredible support marks a pivotal moment for our company as we embark on the next chapter of our journey. This grant will enable us to: 🌍 File patents for our cutting-edge inhibitory molecule detection technology across multiple countries – a major step forward in our mission to innovate on a global scale. 🔐 Strengthen our intellectual property protection within our distribution contracts – ensuring that our innovations are safeguarded as we expand our reach. 🏆 Protect our brand image – reinforcing the trust and integrity that our clients and partners have come to expect from IVANO Bioscience. We are also thankful to District 3 Innovation, Margaret Bywater-Ekegärd, Christian Ménard, and Vincent Bergeron for guiding us through this critical milestone successfully. Here’s to new horizons and continued innovation! 🚀 #Innovation #Bioscience #IntellectualProperty #GlobalExpansion #IVANOBioscience
-
🚀 Advancing Influenza Research with Our 4 Pseudovirus Panel 🧬 We’re excited to introduce our comprehensive panel of 4 pseudoviruses, designed to empower researchers in the development of vaccines and treatments against influenza. 🔒 Safety First: Our pseudoviruses provide a secure environment for experimentation, eliminating the risks associated with live viruses while still offering reliable data. 📈 Efficiency Unleashed: With our high-yield production, researchers receive a generous supply of pseudoviruses, enabling more extensive testing and faster results. ✅ Functional Validation: Each production batch undergoes rigorous functional validation, ensuring consistent and reliable performance in your research. Together, these innovating biotools help accelerate the path to effective influenza solutions. Let's fight the flu with more confidence, safety, and efficiency. 💪 #InfluenzaResearch #VaccineDevelopment #Biotechnology #Pseudovirus #UniversalFluVaccine
-
Looking for a PhD project in the field of biomanufacturing with industrial applications? 👨🔬 We are seeking an exceptional candidate eager to engage in innovative projects at a dynamic start-up based in Quebec City. 💡 The project aims to optimize and deploy a groundbreaking technology to accelerate the development of vaccines and antivirals. In collaboration with Professor Bruno Gaillet, the project will take place in the laboratories of the Department of Chemical Engineering at Université Laval. This project is supported by the Le Pôle de Préparation aux Pandémies de l’Est du Canada/ Eastern Canada Pandemic Preparedness Hub, including the National Research Council Canada / Conseil national de recherches Canada. Additionally, several other projects are also available with Professor Alain Garnier, and in partnership with Feldan Therapeutics. #vaccin #biofabrication #canada